| Name | Evixapodlin |
|---|
| Description | Evixapodlin is a highly potent, small molecule human PD-1/PD-L1 protein-protein interaction inhibitor with IC50 of 0.213 nM, exhibits potential anticancer and antiviral activities. |
|---|---|
| References | 1. Patent WO2019160882A1 (compound number 139). |
| Molecular Formula | C34H36Cl2N8O4 |
|---|---|
| Molecular Weight | 691.61 |